| Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer … MP Coleman, D Forman, H Bryant, J Butler, B Rachet, C Maringe, U Nur, ... The Lancet 377 (9760), 127-138, 2011 | 1484 | 2011 |
| COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England MM Mafham, E Spata, R Goldacre, D Gair, P Curnow, M Bray, S Hollings, ... The Lancet 396 (10248), 381-389, 2020 | 721 | 2020 |
| Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study NP West, EJA Morris, O Rotimi, A Cairns, PJ Finan, P Quirke The lancet oncology 9 (9), 857-865, 2008 | 554 | 2008 |
| Global trends in colorectal cancer mortality: projections to the year 2035 M Araghi, I Soerjomataram, M Jenkins, J Brierley, E Morris, F Bray, ... International journal of cancer 144 (12), 2992-3000, 2019 | 477 | 2019 |
| Surgical management and outcomes of colorectal cancer liver metastases EJA Morris, D Forman, JD Thomas, P Quirke, EF Taylor, L Fairley, ... Journal of British Surgery 97 (7), 1110-1118, 2010 | 416 | 2010 |
| Palliative biliary stents for obstructing pancreatic carcinoma AC Moss, E Morris, P MacMathuna Cochrane database of systematic reviews, 2006 | 393 | 2006 |
| Thirty-day postoperative mortality after colorectal cancer surgery in England EJA Morris, EF Taylor, JD Thomas, P Quirke, PJ Finan, MP Coleman, ... Gut 60 (6), 806-813, 2011 | 342 | 2011 |
| Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study EJA Morris, R Goldacre, E Spata, M Mafham, PJ Finan, J Shelton, ... The lancet Gastroenterology & hepatology 6 (3), 199-208, 2021 | 314 | 2021 |
| Reporting colorectal cancer P Quirke, E Morris Histopathology 50 (1), 103-112, 2007 | 276 | 2007 |
| World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer MD Rutter, I Beintaris, R Valori, HM Chiu, DA Corley, M Cuatrecasas, ... Gastroenterology 155 (3), 909-925. e3, 2018 | 273 | 2018 |
| Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results AC Moss, E Morris, J Leyden, P MacMathuna Cancer treatment reviews 33 (2), 213-221, 2007 | 271 | 2007 |
| Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007 C Maringe, S Walters, B Rachet, J Butler, T Fields, P Finan, R Maxwell, ... Acta oncologica 52 (5), 919-932, 2013 | 249 | 2013 |
| Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction AC Moss, E Morris, J Leyden, P MacMathuna European journal of gastroenterology & hepatology 19 (12), 1119-1124, 2007 | 246 | 2007 |
| Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? E Morris, P Quirke, JD Thomas, L Fairley, B Cottier, D Forman Gut 57 (12), 1690-1697, 2008 | 218 | 2008 |
| Emergency presentation of cancer and short-term mortality S McPhail, L Elliss-Brookes, J Shelton, A Ives, M Greenslade, S Vernon, ... British journal of cancer 109 (8), 2027-2034, 2013 | 202 | 2013 |
| Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist EJA Morris, NJ Maughan, D Forman, P Quirke Journal of clinical oncology 25 (18), 2573-2579, 2007 | 171 | 2007 |
| Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis A Downing, EJA Morris, M Richards, J Corner, P Wright, ... Journal of clinical oncology 33 (6), 616-624, 2015 | 164 | 2015 |
| Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC … EJA Morris, MD Rutter, PJ Finan, JD Thomas, R Valori Gut 64 (8), 1248-1256, 2015 | 162 | 2015 |
| Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology EJA Morris, NJ Maughan, D Forman, P Quirke Gut 56 (10), 1419-1425, 2007 | 162 | 2007 |
| High hospital research participation and improved colorectal cancer survival outcomes: a population-based study A Downing, EJA Morris, N Corrigan, D Sebag-Montefiore, PJ Finan, ... Gut 66 (1), 89-96, 2017 | 159 | 2017 |
